Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles.

Shaker, Mohamed A; Elbadawy, Hossein M; Al Thagfan, Sultan S; Shaker, Mahmoud A

Shaker, Mohamed A; Elbadawy, Hossein M; Al Thagfan, Sultan S; Shaker, Mahmoud A.

Afiliação

Shaker MA; Pharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, PO Box 30040, Taibah University, Al-Madina Al-Munawara, Saudi Arabia; Pharmaceutics Department, Faculty of Pharmacy, Helwan University, PO Box 11795, Cairo, Egypt. Electronic address: mshaker@mun.ca.
Elbadawy HM; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madina Al-Munawara, Saudi Arabia.
Al Thagfan SS; Clinical and Hospital Pharmacy Department, College of Pharmacy, Taibah University, Al-Madina Al-Munawara, Saudi Arabia.
Shaker MA; Department of Pharmaceutics, Faculty of Pharmacy, King Khalid University, Abha, Saudi Arabia.

Int J Pharm ; 592: 120077, 2021 Jan 05.

Article em En | MEDLINE | ID: mdl-33246047

Assuntos

Portadores de Fármacos; Nanopartículas; Administração Oral; Animais; Atorvastatina; Disponibilidade Biológica; Tamanho da Partícula; Coelhos

Palavras-chave

Atorvastatin; Ethylcellulose; Nanoparticles; Oral administration; Oral bioavailability

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas Limite: Animals Idioma: En Revista: Int J Pharm Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google